- call +1-201-465-4211
- email sales@marketquest.biz
- Call +1-201-465-4211
- Email: sales@marketquest.biz
The Influenzavirus B Infection Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Influenzavirus B Infection Drug size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global Influenzavirus B Infection Drug market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Influenzavirus B Infection Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
APP-309
CF-403
GC-3106A
KIN-1400
Others
Market segment by Application can be divided into
Clinic
Hospital
Others
The key market players for global Influenzavirus B Infection Drug market are listed below:
AbbVie Inc
Adimmune Corp
Altravax Inc
Amarillo Biosciences Inc
Aphios Corp
BioCryst Pharmaceuticals Inc
Cadila Healthcare Ltd
ContraFect Corp
Daiichi Sankyo Company Ltd
Fujifilm Holdings Corporation
GlaxoSmithKline Plc
Green Cross Corp
Inovio Pharmaceuticals Inc
Kineta Inc
Medicago Inc
MedImmune LLC
Mucosis BV
Novavax Inc
Park Active Molecules
Romark Laboratories LC
Sanofi
Sanofi Pasteur SA
Shionogi & Co Ltd
SK Chemicals Co Ltd
TSRL Inc
Vaxart Inc
Vectura Group Plc
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe Influenzavirus B Infection Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Influenzavirus B Infection Drug, with price, sales, revenue and global market share of Influenzavirus B Infection Drug from 2019 to 2021.
Chapter 3, the Influenzavirus B Infection Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Influenzavirus B Infection Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2016 to 2026.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2016 to 2026.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and Influenzavirus B Infection Drug market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe Influenzavirus B Infection Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Influenzavirus B Infection Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Influenzavirus B Infection Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 APP-309
1.2.3 CF-403
1.2.4 GC-3106A
1.2.5 KIN-1400
1.2.6 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Influenzavirus B Infection Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Global Influenzavirus B Infection Drug Market Size & Forecast
1.4.1 Global Influenzavirus B Infection Drug Sales in Value (2016-2026))
1.4.2 Global Influenzavirus B Infection Drug Sales in Volume (2016-2026)
1.4.3 Global Influenzavirus B Infection Drug Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Influenzavirus B Infection Drug Production Capacity Analysis
1.5.1 Global Influenzavirus B Infection Drug Total Production Capacity (2016-2026)
1.5.2 Global Influenzavirus B Infection Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Influenzavirus B Infection Drug Market Drivers
1.6.2 Influenzavirus B Infection Drug Market Restraints
1.6.3 Influenzavirus B Infection Drug Trends Analysis
2 Manufacturers Profiles
2.1 AbbVie Inc
2.1.1 AbbVie Inc Details
2.1.2 AbbVie Inc Major Business
2.1.3 AbbVie Inc Influenzavirus B Infection Drug Product and Services
2.1.4 AbbVie Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Adimmune Corp
2.2.1 Adimmune Corp Details
2.2.2 Adimmune Corp Major Business
2.2.3 Adimmune Corp Influenzavirus B Infection Drug Product and Services
2.2.4 Adimmune Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Altravax Inc
2.3.1 Altravax Inc Details
2.3.2 Altravax Inc Major Business
2.3.3 Altravax Inc Influenzavirus B Infection Drug Product and Services
2.3.4 Altravax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Amarillo Biosciences Inc
2.4.1 Amarillo Biosciences Inc Details
2.4.2 Amarillo Biosciences Inc Major Business
2.4.3 Amarillo Biosciences Inc Influenzavirus B Infection Drug Product and Services
2.4.4 Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Aphios Corp
2.5.1 Aphios Corp Details
2.5.2 Aphios Corp Major Business
2.5.3 Aphios Corp Influenzavirus B Infection Drug Product and Services
2.5.4 Aphios Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 BioCryst Pharmaceuticals Inc
2.6.1 BioCryst Pharmaceuticals Inc Details
2.6.2 BioCryst Pharmaceuticals Inc Major Business
2.6.3 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
2.6.4 BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 Cadila Healthcare Ltd
2.7.1 Cadila Healthcare Ltd Details
2.7.2 Cadila Healthcare Ltd Major Business
2.7.3 Cadila Healthcare Ltd Influenzavirus B Infection Drug Product and Services
2.7.4 Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 ContraFect Corp
2.8.1 ContraFect Corp Details
2.8.2 ContraFect Corp Major Business
2.8.3 ContraFect Corp Influenzavirus B Infection Drug Product and Services
2.8.4 ContraFect Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Daiichi Sankyo Company Ltd
2.9.1 Daiichi Sankyo Company Ltd Details
2.9.2 Daiichi Sankyo Company Ltd Major Business
2.9.3 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product and Services
2.9.4 Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Fujifilm Holdings Corporation
2.10.1 Fujifilm Holdings Corporation Details
2.10.2 Fujifilm Holdings Corporation Major Business
2.10.3 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product and Services
2.10.4 Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 GlaxoSmithKline Plc
2.11.1 GlaxoSmithKline Plc Details
2.11.2 GlaxoSmithKline Plc Major Business
2.11.3 GlaxoSmithKline Plc Influenzavirus B Infection Drug Product and Services
2.11.4 GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Green Cross Corp
2.12.1 Green Cross Corp Details
2.12.2 Green Cross Corp Major Business
2.12.3 Green Cross Corp Influenzavirus B Infection Drug Product and Services
2.12.4 Green Cross Corp Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.13 Inovio Pharmaceuticals Inc
2.13.1 Inovio Pharmaceuticals Inc Details
2.13.2 Inovio Pharmaceuticals Inc Major Business
2.13.3 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
2.13.4 Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.14 Kineta Inc
2.14.1 Kineta Inc Details
2.14.2 Kineta Inc Major Business
2.14.3 Kineta Inc Influenzavirus B Infection Drug Product and Services
2.14.4 Kineta Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.15 Medicago Inc
2.15.1 Medicago Inc Details
2.15.2 Medicago Inc Major Business
2.15.3 Medicago Inc Influenzavirus B Infection Drug Product and Services
2.15.4 Medicago Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.16 MedImmune LLC
2.16.1 MedImmune LLC Details
2.16.2 MedImmune LLC Major Business
2.16.3 MedImmune LLC Influenzavirus B Infection Drug Product and Services
2.16.4 MedImmune LLC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.17 Mucosis BV
2.17.1 Mucosis BV Details
2.17.2 Mucosis BV Major Business
2.17.3 Mucosis BV Influenzavirus B Infection Drug Product and Services
2.17.4 Mucosis BV Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.18 Novavax Inc
2.18.1 Novavax Inc Details
2.18.2 Novavax Inc Major Business
2.18.3 Novavax Inc Influenzavirus B Infection Drug Product and Services
2.18.4 Novavax Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.19 Park Active Molecules
2.19.1 Park Active Molecules Details
2.19.2 Park Active Molecules Major Business
2.19.3 Park Active Molecules Influenzavirus B Infection Drug Product and Services
2.19.4 Park Active Molecules Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.20 Romark Laboratories LC
2.20.1 Romark Laboratories LC Details
2.20.2 Romark Laboratories LC Major Business
2.20.3 Romark Laboratories LC Influenzavirus B Infection Drug Product and Services
2.20.4 Romark Laboratories LC Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.21 Sanofi
2.21.1 Sanofi Details
2.21.2 Sanofi Major Business
2.21.3 Sanofi Influenzavirus B Infection Drug Product and Services
2.21.4 Sanofi Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.22 Sanofi Pasteur SA
2.22.1 Sanofi Pasteur SA Details
2.22.2 Sanofi Pasteur SA Major Business
2.22.3 Sanofi Pasteur SA Influenzavirus B Infection Drug Product and Services
2.22.4 Sanofi Pasteur SA Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.23 Shionogi & Co Ltd
2.23.1 Shionogi & Co Ltd Details
2.23.2 Shionogi & Co Ltd Major Business
2.23.3 Shionogi & Co Ltd Influenzavirus B Infection Drug Product and Services
2.23.4 Shionogi & Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.24 SK Chemicals Co Ltd
2.24.1 SK Chemicals Co Ltd Details
2.24.2 SK Chemicals Co Ltd Major Business
2.24.3 SK Chemicals Co Ltd Influenzavirus B Infection Drug Product and Services
2.24.4 SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.25 TSRL Inc
2.25.1 TSRL Inc Details
2.25.2 TSRL Inc Major Business
2.25.3 TSRL Inc Influenzavirus B Infection Drug Product and Services
2.25.4 TSRL Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.26 Vaxart Inc
2.26.1 Vaxart Inc Details
2.26.2 Vaxart Inc Major Business
2.26.3 Vaxart Inc Influenzavirus B Infection Drug Product and Services
2.26.4 Vaxart Inc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.27 Vectura Group Plc
2.27.1 Vectura Group Plc Details
2.27.2 Vectura Group Plc Major Business
2.27.3 Vectura Group Plc Influenzavirus B Infection Drug Product and Services
2.27.4 Vectura Group Plc Influenzavirus B Infection Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 Influenzavirus B Infection Drug Sales by Manufacturer
3.1 Global Influenzavirus B Infection Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Influenzavirus B Infection Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Influenzavirus B Infection Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Influenzavirus B Infection Drug Manufacturer Market Share
3.4.2 Top 6 Influenzavirus B Infection Drug Manufacturer Market Share
3.5 Global Influenzavirus B Infection Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Influenzavirus B Infection Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Influenzavirus B Infection Drug Market Size by Region
4.1.1 Global Influenzavirus B Infection Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Influenzavirus B Infection Drug Revenue by Region (2016-2026)
4.2 North America Influenzavirus B Infection Drug Revenue (2016-2026)
4.3 Europe Influenzavirus B Infection Drug Revenue (2016-2026)
4.4 Asia-Pacific Influenzavirus B Infection Drug Revenue (2016-2026)
4.5 South America Influenzavirus B Infection Drug Revenue (2016-2026)
4.6 Middle East and Africa Influenzavirus B Infection Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Influenzavirus B Infection Drug Sales in Volume by Type (2016-2026)
5.2 Global Influenzavirus B Infection Drug Revenue by Type (2016-2026)
5.3 Global Influenzavirus B Infection Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Influenzavirus B Infection Drug Sales in Volume by Application (2016-2026)
6.2 Global Influenzavirus B Infection Drug Revenue by Application (2016-2026)
6.3 Global Influenzavirus B Infection Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Influenzavirus B Infection Drug Sales by Type (2016-2026)
7.2 North America Influenzavirus B Infection Drug Sales by Application (2016-2026)
7.3 North America Influenzavirus B Infection Drug Market Size by Country
7.3.1 North America Influenzavirus B Infection Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Influenzavirus B Infection Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Influenzavirus B Infection Drug Sales by Type (2016-2026)
8.2 Europe Influenzavirus B Infection Drug Sales by Application (2016-2026)
8.3 Europe Influenzavirus B Infection Drug Market Size by Country
8.3.1 Europe Influenzavirus B Infection Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Influenzavirus B Infection Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Influenzavirus B Infection Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Influenzavirus B Infection Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Influenzavirus B Infection Drug Market Size by Region
9.3.1 Asia-Pacific Influenzavirus B Infection Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Influenzavirus B Infection Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Influenzavirus B Infection Drug Sales by Type (2016-2026)
10.2 South America Influenzavirus B Infection Drug Sales by Application (2016-2026)
10.3 South America Influenzavirus B Infection Drug Market Size by Country
10.3.1 South America Influenzavirus B Infection Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Influenzavirus B Infection Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Influenzavirus B Infection Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Influenzavirus B Infection Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Influenzavirus B Infection Drug Market Size by Country
11.3.1 Middle East & Africa Influenzavirus B Infection Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Influenzavirus B Infection Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Influenzavirus B Infection Drug Typical Distributors
12.3 Influenzavirus B Infection Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
List of Tables
Table 1. Global Influenzavirus B Infection Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Influenzavirus B Infection Drug Revenue by Application, (USD Million), 2021-2026
Table 3. AbbVie Inc Basic Information, Manufacturing Base and Competitors
Table 4. AbbVie Inc Major Business
Table 5. AbbVie Inc Influenzavirus B Infection Drug Product and Services
Table 6. AbbVie Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Adimmune Corp Basic Information, Manufacturing Base and Competitors
Table 8. Adimmune Corp Major Business
Table 9. Adimmune Corp Influenzavirus B Infection Drug Product and Services
Table 10. Adimmune Corp Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Altravax Inc Basic Information, Manufacturing Base and Competitors
Table 12. Altravax Inc Major Business
Table 13. Altravax Inc Influenzavirus B Infection Drug Product and Services
Table 14. Altravax Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Amarillo Biosciences Inc Basic Information, Manufacturing Base and Competitors
Table 16. Amarillo Biosciences Inc Major Business
Table 17. Amarillo Biosciences Inc Influenzavirus B Infection Drug Product and Services
Table 18. Amarillo Biosciences Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Aphios Corp Basic Information, Manufacturing Base and Competitors
Table 20. Aphios Corp Major Business
Table 21. Aphios Corp Influenzavirus B Infection Drug Product and Services
Table 22. Aphios Corp Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. BioCryst Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 24. BioCryst Pharmaceuticals Inc Major Business
Table 25. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
Table 26. BioCryst Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Cadila Healthcare Ltd Basic Information, Manufacturing Base and Competitors
Table 28. Cadila Healthcare Ltd Major Business
Table 29. Cadila Healthcare Ltd Influenzavirus B Infection Drug Product and Services
Table 30. Cadila Healthcare Ltd Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. ContraFect Corp Basic Information, Manufacturing Base and Competitors
Table 32. ContraFect Corp Major Business
Table 33. ContraFect Corp Influenzavirus B Infection Drug Product and Services
Table 34. ContraFect Corp Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Daiichi Sankyo Company Ltd Basic Information, Manufacturing Base and Competitors
Table 36. Daiichi Sankyo Company Ltd Major Business
Table 37. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Product and Services
Table 38. Daiichi Sankyo Company Ltd Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Fujifilm Holdings Corporation Basic Information, Manufacturing Base and Competitors
Table 40. Fujifilm Holdings Corporation Major Business
Table 41. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Product and Services
Table 42. Fujifilm Holdings Corporation Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GlaxoSmithKline Plc Basic Information, Manufacturing Base and Competitors
Table 44. GlaxoSmithKline Plc Major Business
Table 45. GlaxoSmithKline Plc Influenzavirus B Infection Drug Product and Services
Table 46. GlaxoSmithKline Plc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Green Cross Corp Basic Information, Manufacturing Base and Competitors
Table 48. Green Cross Corp Major Business
Table 49. Green Cross Corp Influenzavirus B Infection Drug Product and Services
Table 50. Green Cross Corp Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Inovio Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 52. Inovio Pharmaceuticals Inc Major Business
Table 53. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Product and Services
Table 54. Inovio Pharmaceuticals Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Kineta Inc Basic Information, Manufacturing Base and Competitors
Table 56. Kineta Inc Major Business
Table 57. Kineta Inc Influenzavirus B Infection Drug Product and Services
Table 58. Kineta Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Medicago Inc Basic Information, Manufacturing Base and Competitors
Table 60. Medicago Inc Major Business
Table 61. Medicago Inc Influenzavirus B Infection Drug Product and Services
Table 62. Medicago Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. MedImmune LLC Basic Information, Manufacturing Base and Competitors
Table 64. MedImmune LLC Major Business
Table 65. MedImmune LLC Influenzavirus B Infection Drug Product and Services
Table 66. MedImmune LLC Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Mucosis BV Basic Information, Manufacturing Base and Competitors
Table 68. Mucosis BV Major Business
Table 69. Mucosis BV Influenzavirus B Infection Drug Product and Services
Table 70. Mucosis BV Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Novavax Inc Basic Information, Manufacturing Base and Competitors
Table 72. Novavax Inc Major Business
Table 73. Novavax Inc Influenzavirus B Infection Drug Product and Services
Table 74. Novavax Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 75. Park Active Molecules Basic Information, Manufacturing Base and Competitors
Table 76. Park Active Molecules Major Business
Table 77. Park Active Molecules Influenzavirus B Infection Drug Product and Services
Table 78. Park Active Molecules Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 79. Romark Laboratories LC Basic Information, Manufacturing Base and Competitors
Table 80. Romark Laboratories LC Major Business
Table 81. Romark Laboratories LC Influenzavirus B Infection Drug Product and Services
Table 82. Romark Laboratories LC Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 83. Sanofi Basic Information, Manufacturing Base and Competitors
Table 84. Sanofi Major Business
Table 85. Sanofi Influenzavirus B Infection Drug Product and Services
Table 86. Sanofi Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 87. Sanofi Pasteur SA Basic Information, Manufacturing Base and Competitors
Table 88. Sanofi Pasteur SA Major Business
Table 89. Sanofi Pasteur SA Influenzavirus B Infection Drug Product and Services
Table 90. Sanofi Pasteur SA Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 91. Shionogi & Co Ltd Basic Information, Manufacturing Base and Competitors
Table 92. Shionogi & Co Ltd Major Business
Table 93. Shionogi & Co Ltd Influenzavirus B Infection Drug Product and Services
Table 94. Shionogi & Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 95. SK Chemicals Co Ltd Basic Information, Manufacturing Base and Competitors
Table 96. SK Chemicals Co Ltd Major Business
Table 97. SK Chemicals Co Ltd Influenzavirus B Infection Drug Product and Services
Table 98. SK Chemicals Co Ltd Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 99. TSRL Inc Basic Information, Manufacturing Base and Competitors
Table 100. TSRL Inc Major Business
Table 101. TSRL Inc Influenzavirus B Infection Drug Product and Services
Table 102. TSRL Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 103. Vaxart Inc Basic Information, Manufacturing Base and Competitors
Table 104. Vaxart Inc Major Business
Table 105. Vaxart Inc Influenzavirus B Infection Drug Product and Services
Table 106. Vaxart Inc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 107. Vectura Group Plc Basic Information, Manufacturing Base and Competitors
Table 108. Vectura Group Plc Major Business
Table 109. Vectura Group Plc Influenzavirus B Infection Drug Product and Services
Table 110. Vectura Group Plc Influenzavirus B Infection Drug Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 111. Global Influenzavirus B Infection Drug Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 112. Global Influenzavirus B Infection Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 113. Market Position of Manufacturers in Influenzavirus B Infection Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 114. Global Influenzavirus B Infection Drug Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 115. Head Office and Influenzavirus B Infection Drug Production Site of Key Manufacturer
Table 116. Influenzavirus B Infection Drug New Entrant and Capacity Expansion Plans
Table 117. Influenzavirus B Infection Drug Mergers & Acquisitions in the Past Five Years
Table 118. Global Influenzavirus B Infection Drug Sales by Region (2016-2021e) & (K Pcs)
Table 119. Global Influenzavirus B Infection Drug Sales by Region (2021-2026) & (K Pcs)
Table 120. Global Influenzavirus B Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 121. Global Influenzavirus B Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 122. Global Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 123. Global Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 124. Global Influenzavirus B Infection Drug Revenue by Type (2016-2021e) & (USD Million)
Table 125. Global Influenzavirus B Infection Drug Revenue by Type (2021-2026) & (USD Million)
Table 126. Global Influenzavirus B Infection Drug Price by Type (2016-2021e) & (USD/Pcs)
Table 127. Global Influenzavirus B Infection Drug Price by Type (2021-2026) & (USD/Pcs)
Table 128. Global Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 129. Global Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 130. Global Influenzavirus B Infection Drug Revenue by Application (2016-2021e) & (USD Million)
Table 131. Global Influenzavirus B Infection Drug Revenue by Application (2021-2026) & (USD Million)
Table 132. Global Influenzavirus B Infection Drug Price by Application (2016-2021e) & (USD/Pcs)
Table 133. Global Influenzavirus B Infection Drug Price by Application (2021-2026) & (USD/Pcs)
Table 134. North America Influenzavirus B Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 135. North America Influenzavirus B Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 136. North America Influenzavirus B Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 137. North America Influenzavirus B Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 138. North America Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 139. North America Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 140. North America Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 141. North America Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 142. Europe Influenzavirus B Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 143. Europe Influenzavirus B Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 144. Europe Influenzavirus B Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 145. Europe Influenzavirus B Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 146. Europe Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 147. Europe Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 148. Europe Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 149. Europe Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 150. Asia-Pacific Influenzavirus B Infection Drug Sales by Region (2016-2021e) & (K Pcs)
Table 151. Asia-Pacific Influenzavirus B Infection Drug Sales by Region (2021-2026) & (K Pcs)
Table 152. Asia-Pacific Influenzavirus B Infection Drug Revenue by Region (2016-2021e) & (USD Million)
Table 153. Asia-Pacific Influenzavirus B Infection Drug Revenue by Region (2021-2026) & (USD Million)
Table 154. Asia-Pacific Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 155. Asia-Pacific Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 156. Asia-Pacific Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 157. Asia-Pacific Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 158. South America Influenzavirus B Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 159. South America Influenzavirus B Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 160. South America Influenzavirus B Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 161. South America Influenzavirus B Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 162. South America Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 163. South America Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 164. South America Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 165. South America Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 166. Middle East & Africa Influenzavirus B Infection Drug Sales by Country (2016-2021e) & (K Pcs)
Table 167. Middle East & Africa Influenzavirus B Infection Drug Sales by Country (2021-2026) & (K Pcs)
Table 168. Middle East & Africa Influenzavirus B Infection Drug Revenue by Country (2016-2021e) & (USD Million)
Table 169. Middle East & Africa Influenzavirus B Infection Drug Revenue by Country (2021-2026) & (USD Million)
Table 170. Middle East & Africa Influenzavirus B Infection Drug Sales by Type (2016-2021e) & (K Pcs)
Table 171. Middle East & Africa Influenzavirus B Infection Drug Sales by Type (2021-2026) & (K Pcs)
Table 172. Middle East & Africa Influenzavirus B Infection Drug Sales by Application (2016-2021e) & (K Pcs)
Table 173. Middle East & Africa Influenzavirus B Infection Drug Sales by Application (2021-2026) & (K Pcs)
Table 174. Direct Channel Pros & Cons
Table 175. Indirect Channel Pros & Cons
Table 176. Influenzavirus B Infection Drug Typical Distributors
Table 177. Influenzavirus B Infection Drug Typical Customers
List of Figures
Figure 1. Influenzavirus B Infection Drug Picture
Figure 2. Global Influenzavirus B Infection Drug Sales Market Share by Type in 2020
Figure 3. APP-309
Figure 4. CF-403
Figure 5. GC-3106A
Figure 6. KIN-1400
Figure 7. Others
Figure 8. Global Influenzavirus B Infection Drug Sales Market Share by Application in 2020
Figure 9. Clinic
Figure 10. Hospital
Figure 11. Others
Figure 12. Global Influenzavirus B Infection Drug Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 13. Global Influenzavirus B Infection Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 14. Global Influenzavirus B Infection Drug Sales (2016-2026) & (K Pcs)
Figure 15. Global Influenzavirus B Infection Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 16. Global Influenzavirus B Infection Drug Production Capacity (2016-2026) & (K Pcs)
Figure 17. Global Influenzavirus B Infection Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 18. Influenzavirus B Infection Drug Market Drivers
Figure 19. Influenzavirus B Infection Drug Market Restraints
Figure 20. Influenzavirus B Infection Drug Market Trends
Figure 21. Global Influenzavirus B Infection Drug Sales Market Share by Manufacturer in 2020
Figure 22. Global Influenzavirus B Infection Drug Revenue Market Share by Manufacturer in 2020
Figure 23. Influenzavirus B Infection Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 24. Top 3 Influenzavirus B Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 25. Top 6 Influenzavirus B Infection Drug Manufacturer (Revenue) Market Share in 2020
Figure 26. Global Influenzavirus B Infection Drug Sales Market Share by Region (2016-2026)
Figure 27. Global Influenzavirus B Infection Drug Revenue Market Share by Region (2016-2026)
Figure 28. North America Influenzavirus B Infection Drug Revenue (2016-2026) & (USD Million)
Figure 29. Europe Influenzavirus B Infection Drug Revenue (2016-2026) & (USD Million)
Figure 30. Asia-Pacific Influenzavirus B Infection Drug Revenue (2016-2026) & (USD Million)
Figure 31. South America Influenzavirus B Infection Drug Revenue (2016-2026) & (USD Million)
Figure 32. Middle East & Africa Influenzavirus B Infection Drug Revenue (2016-2026) & (USD Million)
Figure 33. Global Influenzavirus B Infection Drug Sales Market Share by Type (2016-2026)
Figure 34. Global Influenzavirus B Infection Drug Revenue Market Share by Type (2016-2026)
Figure 35. Global Influenzavirus B Infection Drug Price by Type (2016-2026) & (USD/Pcs)
Figure 36. Global Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 37. Global Influenzavirus B Infection Drug Revenue Market Share by Application (2016-2026)
Figure 38. Global Influenzavirus B Infection Drug Price by Application (2016-2026) & (USD/Pcs)
Figure 39. North America Influenzavirus B Infection Drug Sales Market Share by Type (2016-2026)
Figure 40. North America Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 41. North America Influenzavirus B Infection Drug Sales Market Share by Country (2016-2026)
Figure 42. North America Influenzavirus B Infection Drug Revenue Market Share by Country (2016-2026)
Figure 43. United States Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Canada Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 45. Mexico Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Europe Influenzavirus B Infection Drug Sales Market Share by Type (2016-2026)
Figure 47. Europe Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 48. Europe Influenzavirus B Infection Drug Sales Market Share by Country (2016-2026)
Figure 49. Europe Influenzavirus B Infection Drug Revenue Market Share by Country (2016-2026)
Figure 50. Germany Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. France Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. United Kingdom Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Russia Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Italy Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Asia-Pacific Influenzavirus B Infection Drug Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 57. Asia-Pacific Influenzavirus B Infection Drug Sales Market Share by Region (2016-2026)
Figure 58. Asia-Pacific Influenzavirus B Infection Drug Revenue Market Share by Region (2016-2026)
Figure 59. China Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Korea Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Influenzavirus B Infection Drug Sales Market Share by Type (2016-2026)
Figure 66. South America Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Influenzavirus B Infection Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Influenzavirus B Infection Drug Revenue Market Share by Country (2016-2026)
Figure 69. Brazil Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Argentina Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 71. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Type (2016-2026)
Figure 72. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Application (2016-2026)
Figure 73. Middle East & Africa Influenzavirus B Infection Drug Sales Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Influenzavirus B Infection Drug Revenue Market Share by Country (2016-2026)
Figure 75. Turkey Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Egypt Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Saudi Arabia Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 78. South Africa Influenzavirus B Infection Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
